Chowdhury A A - OmicsDI

Show results for

Unknown (4017)
Proteomics (70)
Transcriptomics (33)
Genomics (13)
Metabolomics (4)
Models (1)

Organisms

Bombyx mori (65)
Schizosaccharomyces pombe (65)
Human immunodeficiency virus 1 (65)
Oryza sativa Indica Group (65)
Sinorhizobium meliloti BL225C (65)
Sus scrofa domesticus (65)
Ostreococcus tauri (65)
Saccharomyces cerevisiae (65)
Synechocystis sp. PCC 6803 (65)
Vitis vinifera (65)
Staphylococcus aureus (65)
Rattus norvegicus (65)
Escherichia coli (65)
Candida albicans (65)
Cyanophora paradoxa (65)
Bursaphelenchus xylophilus (65)
Pseudomonas aeruginosa SJTD-1 (65)
Rhizobium sp. Leaf68 (65)
Canis lupus familiaris (65)
Camelus dromedarius (65)
Entamoeba histolytica (65)
Physcomitrium patens (65)
Methylohalobius crimeensis 10Ki (65)
Homo sapiens (33)
Mus musculus (5)
Saccharomyces cerevisiae (1)
Macaca mulatta (1)
Bos taurus (1)
Escherichia coli (1)
Drosophila melanogaster (1)

Organisms

Homo sapiens (6)
Oryza sativa (1)

Repository

pride (65)
biostudies-arrayexpress (37)
ENA (8)
geo (3)
MetaboLights (3)
PanoramaPublic (2)
BioModels (1)
GNPS (1)
MassIVE (1)

Tissue

Cell culture (20)
Blood plasma (4)
Blood (3)
Permanent cell line cell (3)
Heart (3)
Embryonic fibroblast (2)
Fibroblast (2)
Epithelial cell (2)
Macrophage (2)
Liver (2)
Hepatocyte (2)
Colonocyte (1)
Leg bone (1)
Oral squamous cell carcinoma cell (1)
Ovarian serous carcinoma cell (1)
Breast cancer cell (1)
Kidney cell (1)
Tooth enamel (1)
HEK-293 cell (1)
Erythrocyte (1)
Skeletal muscle (1)
Saliva (1)
Bone marrow (1)
HeLa cell (1)
Intestine (1)
Blood cell (1)
T cell (1)
Testis (1)
Embryonic stem cell (1)

Disease

Long COVID (2)
Breast cancer (2)
Pediatric osteosarcoma (1)
Spinal cord (1)
Non-alcoholic steatohepatitis (1)
Plasmodium falciparum malaria (1)
Thalassemia (1)
Malignant neoplasm of ovary (1)

Technology Type

Mass Spectrometry (65)
Shotgun proteomics (34)
Bottom-up proteomics (12)
Data-dependent acquisition (10)
SWATH MS (7)
Gel-based experiment (4)
Top-down proteomics (4)
Affinity purification coupled with mass spectrometry proteomics (4)
Mass spectrometry (3)
Data-independent acquisition (3)
Chemical cross-linking coupled with mass spectrometry proteomics (2)

Instrument Platform

Illumina HiSeq 4000 (3)
Liquid Chromatography MS - negative - reverse phase (2)
Axon GenePix 4000B scanning hardware (1)
NextSeq 2000 (1)
TSQ Quantum Ultra (1)
Q Exactive Plus (1)
Orbitrap Fusion Lumos (1)
Liquid Chromatography MS - - - LTQ Orbitrap Velos (Thermo Scientific) (1)
Liquid Chromatography MS - positive - reverse phase (1)

Publication Date

2025 (19)
2021 (13)
2024 (12)
2022 (12)
2014 (8)
2015 (7)
2023 (7)
2026 (7)
2011 (5)
2010 (5)
2013 (4)
2018 (4)
2009 (2)
2020 (2)
2019 (2)
2005 (1)
2016 (1)
2012 (1)
2008 (1)

UNIPROT ID/AC

P12351 (1)
P40441 (1)
P25601 (1)
P26188 (1)
P14771 (1)
P38830 (1)
P14164 (1)
P50083 (1)
P47098 (1)
P40587 (1)
P39546 (1)
P32896 (1)
P36039 (1)
P42844 (1)
Q03180 (1)
P12294 (1)
Q12088 (1)
O13527 (1)
P48559 (1)
P25561 (1)
P40068 (1)
P36130 (1)
P50273 (1)
P36004 (1)
P40033 (1)
Q06053 (1)
P46993 (1)
P40851 (1)
P14796 (1)
P38248 (1)

CHEBI ID

CHEBI:15848 (1)
CHEBI:15863 (1)
CHEBI:15705 (1)
CHEBI:17118 (1)
CHEBI:32988 (1)
CHEBI:16468 (1)
CHEBI:17478 (1)
CHEBI:15914 (1)
CHEBI:4280 (1)
CHEBI:28401 (1)
CHEBI:18338 (1)
CHEBI:28260 (1)
CHEBI:18290 (1)
CHEBI:33199 (1)
CHEBI:35910 (1)
CHEBI:16385 (1)
CHEBI:2405 (1)
CHEBI:17106 (1)
CHEBI:17667 (1)
CHEBI:36241 (1)
CHEBI:2070 (1)
CHEBI:16211 (1)
CHEBI:18371 (1)
CHEBI:15678 (1)
CHEBI:15689 (1)
CHEBI:17530 (1)
CHEBI:32952 (1)
CHEBI:27585 (1)
CHEBI:9093 (1)
CHEBI:15494 (1)

Metabolite Name

Pentaethylene glycol monododecyl ether (1)
Dopaquinone (1)
Ursodeoxycholic Acid-D4 (1)
Tauroursodeoxycholic acid-D4 (1)
Taurodeoxycholic acid-D4 (1)
Taurocholic Acid-D4 (1)
Taurochenodeoxycholic Acid-D4 (1)
Lithocholic Acid-D4 (1)
Deoxycholic Acid-D4 (1)
Cholic Acid-D4 (1)
Methylmalonate (1)
Taurochenodeoxycholic Acid (1)
3,4-Dihydroxyphenylpropionic acid (1)
D-mannose 6-phosphate (1)
D-Glucono-1,5-lactone (1)
Alpha,alpha-trehalose (1)
Keto-D-fructose (1)
Glycine betaine (1)
L-isoleucine (1)
Lithocholic Acid (1)
Chlorogenic acid (1)
Citric acid (1)
4-Pyridoxic acid (1)
Ursodeoxycholic Acid (1)
Deoxycholic Acid (1)
Chrysin (1)
Cholic Acid (1)
Tauroursodeoxycholic acid (1)
Taurocholic Acid (1)
Ascorbic acid (1)

IsPrivate

False (1)

Model Flag

Non Kinetic (1)

First Public Date

2026 (4)
2025 (4)

Study type

Transcription profiling by array (16)
RNA-seq of coding RNA (5)
ChIP-chip by tiling array (4)
ChIP-seq (2)
Proteomic profiling by array (2)
RNA-seq of total RNA (2)
RNA-seq of non coding RNA (2)
Unknown experiment type (1)
Other (1)
Methylation profiling by array (1)
Methylation profiling by high throughput sequencing (1)

Release Date

2025 (493)
2022 (488)
2023 (487)
2024 (446)
2021 (428)
2020 (314)
2019 (233)
2018 (212)
2017 (191)
2016 (139)
2015 (130)
2014 (121)
2013 (78)
2026 (69)
2012 (61)
2011 (48)
2010 (33)
2009 (30)
2008 (18)
2006 (10)
2007 (8)
2000 (4)
2005 (3)
2002 (3)
2004 (2)
1998 (2)
2003 (1)
2001 (1)
1999 (1)

Lab affiliation

Bioplatforms Australia (7)
German Cancer Research Center (DKFZ) Cell Signaling and Metabolism Group (2)
Manchester Institute of Biotechnology, University of Manchester, 131 Princess Street, Manchester, M1 7DN, UK Interdisciplinary Centre for Ancient Life, Department of Earth and Environmental Sciences, University of Manchester, Oxford Road 131, Manchester, M13 9PL, UK (2)
Leader of the Molecular and Systems Oncology Team in the Division of Molecular Pathology at The Institute of Cancer Research, London, UK (2)
Department of Internal Medicine, Section on Molecular Medicine, Wake Forest School of Medicine, Winston-Salem, NC, United States (2)
Departments of Immunology and Cell Biology Faculty of Medicine and Health Sciences Université de Sherbrooke Sherbrooke, QC J1H 5N4 Canada (2)
Manchester Institute of Biotechnology, Department of Earth and Environmental Sciences, The University of Manchester (2)
Mass Spectrometry Proteomics Science Technology Platform The Francis Crick Institute (1)
Helmholtz-Zentrum für Umweltforschung GmbH - UFZ Department Molekulare Systembiologie Permoserstraße 15 04318 Leipzig, Germany (1)
Associate Professor, Chemistry and Biochemistry, University of Texas at Arlington (1)
Department of Earth and Environmental Sciences, Manchester Institute of Biotechnology, The University of Manchester (1)
Drug Delivery, Disposition and Dynamics, Monash Institute of Pharmaceutical Sciences, Monash University, Parkville, Australia (1)
Department of Molecular, Cellular, and Developmental Biology (MCDB) at University of California Santa Barbara (UCSB) (1)
The University of Alabama (1)
Associate Professor, Department of Chemistry and Biochemistry, University of Texas At Arlington (1)
Proferssor, Group Leader of Molecular Biology and Human genetics Division, Department of Zoology, The University of Burdwan (1)
Head of Discovery Proteomics Facility (1)
Institute of Biomedical Sciences, Academia Sinica (1)
Bioplatforms Australia (project manager) (1)
Associate Professor, Dept. of Chemistry and Biochemistry, University of Texas at Arlington,TX 76019 (1)
Department of Biological Engineering, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA, USA (1)
Department of Pediatric Oncology Linde Program in Cancer Chemical Biology Dana-Farber Cancer Institute Boston, MA 02215 USA (1)
UK Dementia Research Institute, University of Cambridge, Clifford Albutt building, Cambridge biomedical campus, Cambridge, CB2 0AH, UK (1)
Centre for Misfolding Diseases, Yusuf Hamied Department of Chemistry, University of Cambridge, Cambridge, CB2 1EW, United Kingdom (1)
Columbia University, Department of Biochemistry and Molecular Biophysics, USA (1)
Professor, Department of Biological Sciences, Birla Institute of Technology & Science, Pilani- 333031, Rajasthan. India. (1)
Center for Molecular Medicine and Genetics, Wayne State University, Detroit, MI 48201, USA (1)
Interdisciplinary Centre for Ancient Life, Department of Earth and Environmental Sciences, Manchester Institute of Biotechnology, University of Manchester, Manchester, UK (1)
Division of Radiation and Genome Stability, Dana-Farber Cancer Institute, Harvard Institutes of Medicine, USA (1)
University of edinburgh (1)

Previous page
1 / 414
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 414
Next page

Sort by:

Relevance

Page size

Targeting Alpha Toxin and ClfA with a Multimechanistic Monoclonal-Antibody-Based Approach for Prophylaxis of Serious Staphylococcus aureus Disease.

Not available

S-EPMC4937210 | biostudies-literature

Workplace Bullying and Violence on Burnout Among Bangladeshi Registered Nurses: A Survey Following a Year of the COVID-19 Pandemic.

Not available

S-EPMC9618602 | biostudies-literature

Gene expression profiles of human CD8+ T cells: IL-12 and IFN-a polarized in vitro stimulated and ex vivo sorted CCR7hi and CXCR3hi populations

CD8+ cytotoxic T lymphocytes (CTLs) play a major role in defense against intracellular pathogens, and their functions are specified by antigen recognition and innate cytokines. While effector CTLs eliminate the infection, a small population of memory cells are retained that yields more rapid and rob...

ORGANISM(S): Homo sapiens

2011-09-29 | E-GEOD-27337 | biostudies-arrayexpress

Phase I study assessing the mass balance, pharmacokinetics, and excretion of [¹⁴C]-pevonedistat, a NEDD8-activating enzyme inhibitor in patients with advanced solid tumors.

Not available

S-EPMC7960626 | biostudies-literature

Workplace violence, bullying, burnout, job satisfaction and their correlation with depression among Bangladeshi nurses: A cross-sectional survey during the COVID-19 pandemic.

Not available

S-EPMC9499253 | biostudies-literature

A phase I study to assess the mass balance, excretion, and pharmacokinetics of [¹⁴C]-ixazomib, an oral proteasome inhibitor, in patients with advanced solid tumors.

Not available

S-EPMC5948259 | biostudies-literature

Expression profile of lung adenocarcinoma, A549 cells following targeted depletion of non metastatic 2 (NME2/NM23 H2)

Non-metastatic 2 (NME2) is an established metastases suppressor in multiple human cancer types. However, the molecular mechanisms of NME2 action remain insufficiently resolved. We recently validated the transcription regulatory activity of NME2 with respect to control of proto-oncogene c-MYC express...

ORGANISM(S): Homo sapiens

2011-02-08 | E-GEOD-18182 | biostudies-arrayexpress

Phase I study of the investigational oral mTORC1/2 inhibitor sapanisertib (TAK-228): tolerability and food effects of a milled formulation in patients with advanced solid tumours.

Not available

S-EPMC5812400 | biostudies-literature

Analysing risk factors for diabetes in Bangladesh: a Bayesian hierarchical approach using a nationwide cross-sectional study.

Not available

S-EPMC12487037 | biostudies-literature

Role of women's empowerment in determining fertility and reproductive health in Bangladesh: a systematic literature review.

Not available

S-EPMC10310482 | biostudies-literature